Apolipoprotein e enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial no synthase

Hypertension

Volumn 60, Issue 4, 2012, Pages 1040-1046

  Yue, Lili ^a   Bian, Jing Tan ^b   Grizelj, Ivana ^b   Cavka, Ana ^b   Phillips, Shane A ^a,b   Makino, Ayako ^a   Mazzone, Theodore ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

apolipoprotein E; caveolin 1; endothelium; macrophages; NO; NO synthase

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXYSTEROL; STEROL;

ANIMAL EXPERIMENT; ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VASODILATATION;

ANIMALS; APOLIPOPROTEINS E; CAVEOLIN 1; ENDOTHELIAL CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRA-ABDOMINAL FAT; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84866537810     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.196667     Document Type: Article

References (36)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
2. Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci USA. 1981;78:7545-7549.
3. Zechner R, Moser R, Newman TC, Fried SK, Breslow JL. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem. 1991;266:10583-10588.
4. Fazio S, Babaev VR, Burleigh ME, Major AS, Hasty AH, Linton MF. Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. J Lipid Res. 2002;43:1602-1609.
5. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA. 1997;94:4647-4652.
6. Shi W, Wang X, Wang NJ, McBride WH, Lusis AJ. Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-defcient mice. Arterioscler Thromb Vasc Biol. 2000;20:2261-2266.
7. Mazzone T, Gump H, Diller P, Getz GS. Macrophage free cholesterol content regulates apolipoprotein E synthesis. J Biol Chem. 1987;262:11657-11662.
8. Mazzone T, Basheeruddin K. Dissociated regulation of macrophage LDL receptor and apolipoprotein E gene expression by sterol. J Lipid Res. 1991;32:507-514.
9. Cooper A, HeagertyAM. Endothelial dysfunction in human intramyo-cardial small arteries in atherosclerosis and hypercholesterolemia. Am J Physiol. 1998;275(4 pt 2):H1482-H1488.
10. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens. 2007;25:1021-1026.
11. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic signifcance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
12. Stannard AK, Riddell DR, Sacre SM, Tagalakis AD, Langer C, von EA, Cullen P, Athanasopoulos T, Dickson G, Owen JS. Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion mol-ecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem. 2001;276:46011-46016.
13. Garcia-Cardena G, Fan R, Stern DF, Liu J, Sessa WC. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem. 1996;271:27237-27240.
14. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1179-L1183.
15. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest. 1999;103:897-905.
16. Yue L, Mazzone T. Endogenous adipocyte apolipoprotein E is colo-calized with caveolin at the adipocyte plasma membrane. J Lipid Res. 2011;52:489-498.
17. Phillips SA, Hatoum OA, Gutterman DD. The mechanism of fow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. Am J Physiol Heart Circ Physiol. 2007;292:H93-H100.
18. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta A, Phillips SA, Hari P. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol. 2011;301:H2305-H2312.
19. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS. Mechanism of endothelial dysfunction in apolipoprotein E-defcient mice. Arterioscler Thromb Vasc Biol. 2001;21:1017-1022.
20. Jiang F, Gibson AP, Dusting GJ. Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E defcient mice. Eur J Pharmacol. 2001;424:141-149.
21. Davignon J. Apolipoprotein E and atherosclerosis: beyond lipid effect. Arterioscler Thromb Vasc Biol. 2005;25:267-269.
22. Mazzone T, Reardon C. Expression of heterologous human apolipopro-tein E by J774 macrophages enhances cholesterol effux to HDL3. J Lipid Res. 1994;35:1345-1353.
23. Huang ZH, Lin CY, Oram JF, Mazzone T. Sterol effux mediated by endogenous macrophage ApoE expression is independent of ABCA1. Arterioscler Thromb Vasc Biol. 2001;21:2019-2025.
24. Zanotti I, Pedrelli M, Poti F, Stomeo G, Gomaraschi M, Calabresi L, Bernini F. Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol. 2011;31:74-80.
25. Ishigami M, Swertfeger DK, Hui MS, Granholm NA, Hui DY. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2000;20:1020-1026.
26. Tarnus E, Wassef H, Carmel JF, Rondeau P, Roche M, Davignon J, Bernier L, Bourdon E. Apolipoprotein E limits oxidative stress-induced cell dysfunction in human adipocytes. FEBS Lett. 2009 583:2042-2048.
27. Farb M, Ganley-Leal L, Mott M, Liang Y, Ercan B, Widlansky M, Bigornia S, Fiscale A, Apovian C, Carmine B, Hess D, Vita J, Gokce N. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol. 2012;32:467-473.
28. Fulton D, Gratton J P, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299:818-824.
29. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293:2449-2452.
30. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyper proliferative and vascular abnormalities. J Biol Chem. 2001;276:38121-38138.
31. Murata T, Murata T, Lin MI, Huang Y, Yu J, Bauer PM, Giordano FJ, SessaWCl. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med. 2007;204:2373-2382.
32. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest. 2006;116:1284-1291.
33. 2 and shear stress. Free Radic Biol Med. 2010;49:159-170.
34. Shaul P, Smart E, Robinson L, German Z, Yuhanna I, Ying Y, Anderson R, Michel T. Acylation targets endothelial nitric-oxide synthase to plasma-lemmal caveolae. J Biol Chem. 1996;271:6518-6522.
35. Garcia-Cardena G, Oh P, Liu J, Schnitzer J, Sessa W. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA. 1996;93:6448-6453.
36. Terasaka N, Westerterp M, Koetsveld J, Fernandez-Hernando C, Yvan-Charvet L, Wang N, Sessa W, Tall A. ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. Arterioscler Thromb Vasc Biol. 2010;30:2219-2225.